These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4024956)

  • 21. Emepronium bromide (Cetiprin). Its effect on bladder pressure and urinary flow in healthy subjects.
    Boman J; von Garrelts B
    Scand J Urol Nephrol; 1973; 7(2):153-7. PubMed ID: 4759776
    [No Abstract]   [Full Text] [Related]  

  • 22. Cetiprin (emepronium bromide) in patients with prostatism.
    Br Med J; 1978 Jun; 1(6125):1485. PubMed ID: 77174
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of parenteral emepronium bromide (Cetiprin) on postoperative vesical tenesms after transurethral resection of the prostate. A randomized, placebo-controlled study.
    Jørgensen L; Willumsen H; Lautorp JR; Paaschburg B; Kromann B; Andersen JT
    Int Urol Nephrol; 1987; 19(1):87-90. PubMed ID: 3294714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical observations with Cetiprin (emepronium bromide).
    Hamvas A; Romics I; Balogh F
    Int Urol Nephrol; 1981; 13(2):153-5. PubMed ID: 7327890
    [No Abstract]   [Full Text] [Related]  

  • 25. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability.
    Cardozo LD; Stanton SL
    J Urol; 1979 Jul; 122(1):58-9. PubMed ID: 458990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose titration in clinical trials. An example using emepronium carrageenate in detrusor instability.
    Massey JA; Abrams P
    Br J Urol; 1986 Apr; 58(2):125-8. PubMed ID: 3516295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An urodynamic study of emepronium bromide in bladder dysfunction.
    Ekeland A; Sander S
    Scand J Urol Nephrol; 1976; 10(3):195-9. PubMed ID: 1006180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of emeprone on intravesical and intra-urethral pressure in women with urgency incontinence.
    Ulmsten U; Andersson KE
    Scand J Urol Nephrol; 1977; 11(2):103-9. PubMed ID: 561438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oesophageal injury associated with emepronium bromide (Cetiprin).
    Leonard RC; Adams PC; Parker S; Adams DM
    Br J Clin Pract; 1984; 38(11-12):429-30. PubMed ID: 6529548
    [No Abstract]   [Full Text] [Related]  

  • 30. [Emepronium bromide (Cetiprin) induced mucous membrane lesion].
    Nielsen SK; Mørck HI
    Ugeskr Laeger; 1979 May; 141(20):1346. PubMed ID: 452148
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of nocturnal enuresis with emepronium bromide (Cetiprin). A controlled clinical trial].
    Jensen PO; Jensen PH
    Ugeskr Laeger; 1982 Jul; 144(30):2224-6. PubMed ID: 6755846
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study of the effectiveness of an intravesical administered lidocaine gel versus emepronium bromide in females with urge incontinence].
    Enzelsberger H; Schatten C; Barrada M; Kurz C
    Gynakol Rundsch; 1989; 29 Suppl 2():346-8. PubMed ID: 2613047
    [No Abstract]   [Full Text] [Related]  

  • 33. Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound.
    HANSSON E; SCHMITERLOW CG
    Acta Pharmacol Toxicol (Copenh); 1961; 18():183-90. PubMed ID: 13904475
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of emepronium bromide with intravesical administration of lidocaine gel in women with urge incontinence].
    Enzelsberger H; Schatten C; Kurz C
    Geburtshilfe Frauenheilkd; 1991 Jan; 51(1):54-7. PubMed ID: 2026301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic disposition of emepronium in the dog with a note on the relationship between plasma concentration and effect.
    Sundwall A; Uthne K; Vessman J
    Acta Pharmacol Toxicol (Copenh); 1971; 29(5):385-401. PubMed ID: 5171114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Emepronium (Cetiprin). An urinary bladder specific parasympatholytic].
    Hebjørn S
    Ugeskr Laeger; 1980 Feb; 142(8):536-7. PubMed ID: 7368412
    [No Abstract]   [Full Text] [Related]  

  • 37. Fate of emepronium in man in relation to its pharmacological effects.
    Sundwall A; Vessman J; Strindberg B
    Eur J Clin Pharmacol; 1973 Oct; 6(3):191-5. PubMed ID: 4762058
    [No Abstract]   [Full Text] [Related]  

  • 38. Ulceration due to emepronium bromide tablets.
    Pilbrant A
    Lancet; 1977 Apr; 1(8014):749. PubMed ID: 66539
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of motor dysfunction of the urinary bladder].
    Gaudenz R; Buess H
    Fortschr Med; 1978 Sep; 96(35):1777-82. PubMed ID: 738692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
    Trinchard-Lugan I; Ho-Nguyen Q; Bilham WM; Buraglio M; Ythier A; Munafo A
    Eur Cytokine Netw; 2001; 12(3):391-8. PubMed ID: 11566619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.